These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34719625)

  • 1. Association between Maoto Use and Hospitalization for Seasonal Influenza in a Nonelderly Cohort in Japan.
    Yamana H; Ono S; Michihata N; Jo T; Yasunaga H
    Intern Med; 2021; 60(21):3401-3408. PubMed ID: 34719625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maoto plus neuraminidase inhibitor versus neuraminidase inhibitor alone for reducing hospitalization in older adults with seasonal influenza.
    Yamana H; Sasabuchi Y; Matsui H; Michihata N; Jo T; Yasunaga H
    Ann Clin Epidemiol; 2022; 4(4):120-128. PubMed ID: 38505252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, controlled trial comparing traditional herbal medicine and neuraminidase inhibitors in the treatment of seasonal influenza.
    Nabeshima S; Kashiwagi K; Ajisaka K; Masui S; Takeoka H; Ikematsu H; Kashiwagi S
    J Infect Chemother; 2012 Aug; 18(4):534-43. PubMed ID: 22350323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of maoto (Ma-Huang-Tang), a traditional Japanese Kampo medicine, to alleviate flu symptoms: a systematic review and meta-analysis.
    Yoshino T; Arita R; Horiba Y; Watanabe K
    BMC Complement Altern Med; 2019 Mar; 19(1):68. PubMed ID: 30885188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of Maoto in an influenza season where reduced effectiveness of oseltamivir was observed - a clinical, non-randomized study in children.
    Toriumi Y; Kamei T; Murata K; Takahashi I; Suzuki N; Mazda O
    Forsch Komplementmed; 2012; 19(4):179-86. PubMed ID: 22964983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Hospitalization Incidence in Influenza Outpatients Treated With Baloxavir Marboxil or Neuraminidase Inhibitors: A Health Insurance Claims Database Study.
    Komeda T; Takazono T; Hosogaya N; Miyazaki T; Ogura E; Iwata S; Miyauchi H; Honda K; Fujiwara M; Ajisawa Y; Watanabe H; Kitanishi Y; Hara K; Mukae H
    Clin Infect Dis; 2021 Sep; 73(5):e1181-e1190. PubMed ID: 33354728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy of peramivir in adult patients with seasonal influenza during the winter of 2012 in Japan.
    Yoshino Y; Seo K; Koga I; Kitazawa T; Ota Y
    Clin Respir J; 2015 Apr; 9(2):228-32. PubMed ID: 24612842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The smaller number of influenza patients with neuropsychiatric events had taken oseltamivir beforehand].
    Tomono N; Shiro H
    Kansenshogaku Zasshi; 2008 Nov; 82(6):613-8. PubMed ID: 19086415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spread of viral infection to family members from influenza patients treated with a neuraminidase inhibitor.
    Nakano T; Shiosakai K
    J Infect Chemother; 2014 Jul; 20(7):401-6. PubMed ID: 24787736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends of neuraminidase inhibitors use in children with influenza related respiratory infections.
    Uda K; Okubo Y; Shoji K; Miyairi I; Morisaki N; Michihata N; Matsui H; Fushimi K; Yasunaga H
    Pediatr Pulmonol; 2018 Jun; 53(6):802-808. PubMed ID: 29673121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of neuraminidase inhibitors in preventing hospitalization during the H1N1 influenza pandemic in British Columbia, Canada.
    Marra F; Chong M; Henry B; Patrick DM; Kendall P
    J Antimicrob Chemother; 2014 May; 69(5):1397-406. PubMed ID: 24346762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oseltamivir and the risk of influenza-related complications and hospitalizations in patients with diabetes.
    Orzeck EA; Shi N; Blumentals WA
    Clin Ther; 2007 Oct; 29(10):2246-55. PubMed ID: 18042482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the Clinical Courses of Patients with Influenza after Neuraminidase Inhibitors Treatment: A Postcard Survey of the 2013-2014 Influenza Season in Osaka.
    Yoshi N; Tocino Y; Fujioka M; Kureya Y; Asai K; Kimura T; Shinataku H; Hirata K
    Osaka City Med J; 2016 Dec; 62(2):29-38. PubMed ID: 30550708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the clinical symptoms and the effectiveness of neuraminidase inhibitors for patients with pandemic influenza H1N1 2009 or seasonal H1N1 influenza in the 2007-2008 and 2008-2009 seasons.
    Kawai N; Ikematsu H; Tanaka O; Matsuura S; Maeda T; Yamauchi S; Hirotsu N; Nishimura M; Iwaki N; Kashiwagi S
    J Infect Chemother; 2011 Jun; 17(3):375-81. PubMed ID: 21120678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early therapy with neuraminidase inhibitors for influenza A (H1N1) pdm 2009 infection.
    Yamamoto T; Ihashi M; Mizoguchi Y; Kaneno H; Yamamoto K; Inoue Y; Kase T; Okabe N; Shimotsuji T
    Pediatr Int; 2013 Dec; 55(6):714-21. PubMed ID: 23745743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alleviative Effects of a Kampo (a Japanese Herbal) Medicine "Maoto (Ma-Huang-Tang)" on the Early Phase of Influenza Virus Infection and Its Possible Mode of Action.
    Nagai T; Kataoka E; Aoki Y; Hokari R; Kiyohara H; Yamada H
    Evid Based Complement Alternat Med; 2014; 2014():187036. PubMed ID: 24778699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of the clinical effectiveness of three neuraminidase inhibitors for Japanese pediatric patients with influenza in the 2013/2014 season].
    Hishiki H; Ishiwada N; Naito S; Nagasawa K; Someya T; Inoue N; Haraki M; Kurosaki T; Kameoka Y; Suzuki K
    Jpn J Antibiot; 2015 Dec; 68(6):337-43. PubMed ID: 27004397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring of neuraminidase inhibitor resistance among clinical influenza virus isolates in Japan during the 2003-2006 influenza seasons.
    Wkly Epidemiol Rec; 2007 Apr; 82(17):149-50. PubMed ID: 17465078
    [No Abstract]   [Full Text] [Related]  

  • 19. Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors.
    Hatakeyama S; Sugaya N; Ito M; Yamazaki M; Ichikawa M; Kimura K; Kiso M; Shimizu H; Kawakami C; Koike K; Mitamura K; Kawaoka Y
    JAMA; 2007 Apr; 297(13):1435-42. PubMed ID: 17405969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical effectiveness of neuraminidase inhibitors--oseltamivir, zanamivir, laninamivir, and peramivir--for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010-2011 influenza season in Japan.
    Shobugawa Y; Saito R; Sato I; Kawashima T; Dapat C; Dapat IC; Kondo H; Suzuki Y; Saito K; Suzuki H
    J Infect Chemother; 2012 Dec; 18(6):858-64. PubMed ID: 22644080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.